Oliver Kripfgans

Prof. Oliver Kripfgans


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
OKOliver Kripfgans
Oliver Kripfgans
JFJ.BRian Fowlkes
J.BRian Fowlkes
DMDouglas L. Miller
Douglas L. Miller
OEO.PEtter Eldevik
O.PEtter Eldevik
PCPaul L. Carson
Paul L. Carson

10 January 2007 in Analytical Chemistry
Verified
Journal Article
Closed access
DHDongeun Huh
Dongeun Huh
JBJoong Hwan Bahng
Joong Hwan Bahng
YLYibo Ling
Yibo Ling
HWHsien-Hung Wei
Hsien-Hung Wei
OKOliver Kripfgans
Oliver Kripfgans
STShuichi Takayama
Shuichi Takayama

26 May 2009 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Verified
Journal Article
Closed access
MFM.L. Fabiilli
M.L. Fabiilli
Kevin Joseph HaworthKevin Joseph Haworth
Kevin Joseph Haworth
NFN.H. Fakhri
N.H. Fakhri
OKOliver Kripfgans
Oliver Kripfgans
PCPaul L. Carson
Paul L. Carson
JFJ.B. Fowlkes
J.B. Fowlkes
The vaporization of a superheated droplet emulsion into gas bubbles using ultrasound-termed acoustic droplet vaporization (ADV)-has potential therapeutic applications in embolotherapy and drug delivery. The optimization of ADV for therapeutic applications can be enhanced by understanding the physical mechanisms underlying ADV, which are currently not clearly elucidated. Acoustic cavitation is one possible mechanism. This paper investigates the relationship between ADV and inertial cavitation (IC) thresholds (measured as peak rarefactional pressures) by studying parameters that are known to influence the IC threshold. These parameters include bulk fluid properties such as gas saturation, temperature, viscosity, and surface tension; droplet parameters such as degree of superheat, surfactant type, and size; and acoustic properties such as pulse repetition frequency and pulse width. In all cases the ADV threshold occurred at a lower rarefactional pressure than the IC threshold, indicating that the phase transition occurs before IC events. The viscosity and temperature of the bulk fluid are shown to influence both thresholds directly and inversely, respectively. An inverse trend is observed between threshold and diameter for droplets in the 1 to 2.5 mum range. Based on a choice of experimental parameters, it is possible to achieve ADV with or without IC.

1 July 2004 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
PDF file
OKOliver Kripfgans
Oliver Kripfgans
MFMario L. Fabiilli
Mario L. Fabiilli
PCPaul L. Carson
Paul L. Carson
JFJ. Brian Fowlkes
J. Brian Fowlkes
This paper examines the vaporization of individual dodecafluoropentane droplets by the application of single ultrasonic tone bursts. High speed video microscopy was used to monitor droplets in a flow tube, while a focused, single element transducer operating at 3, 4, or 10 MHz was aimed at the intersection of the acoustical and optical beams. A highly dilute droplet emulsion was injected, and individual droplets were positioned in the two foci. Phase transitions of droplets were produced by rarefactional pressures as low as 4 MPa at 3 MHz using single, 3.25 μs tone bursts. During acoustic irradiation, droplets showed dipole-type oscillations along the acoustic axis (average amplitude 1.3 μm, independent of droplet diameter which ranged from 5 to 27 μm). The onset of vaporization was monitored as either spot-like, within the droplet, or homogeneous, throughout the droplet’s imaged cross section. Spot-like centers of nucleation were observed solely along the axis lying parallel to the direction of oscillation and centered on the droplet. Smaller droplets required more acoustic intensity for vaporization than larger droplets, which is consistent with other experiments on emulsions.

1 September 1999 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
EME L Madsen
E L Madsen
FDF Dong
F Dong
GFG R Frank
G R Frank
BGB S Garra
B S Garra
KWK A Wear
K A Wear
JMJ G Miller
J G Miller

25 September 2010 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
MFMario L. Fabiilli
Mario L. Fabiilli
JLJames A. Lee
James A. Lee
OKOliver Kripfgans
Oliver Kripfgans
PCPaul L. Carson
Paul L. Carson
JFJ. Brian Fowlkes
J. Brian Fowlkes